Phase II Study of Maintenance Pembrolizumab in Small Cell Lung Cancer

Phase II Study of Maintenance Pembrolizumab in Small Cell Lung Cancer

User Photo
AnnualMeeting2017

3 years
746 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Nathan Pennell, MD, PhD of Cleveland Clinic gives an overview of his abstract, which focused on the use of maintenance pembrolizumab in patients with extensive stage small cell lung cancer at the 2017 ASCO Annual Meeting in Chicago, IL. Abstract 8504: Phase II study of maintenance pembrolizumab (pembro) in extensive stage small cell lung cancer (ES-SCLC) patients (pts)
Up Next Autoplay